TREATMENT OF ISCHEMIC STROKE: FOCUS ON NEUROREGENERATION - MODERN STRATEGIES AND PROSPECTS
Keywords:
ischemic stroke, neuroregeneration, cell therapy, exosomes, neurotrophic factor, brain-derived neurotrophic factor, neurotrophin-3, nerve growth factor, vascular endothelial growth factor, gene therapyAbstract
Ischemic stroke is one of the leading causes of disability and mortality worldwide, which emphasizes the need to develop effective therapeutic approaches. The article discusses modern strategies for the treatment of ischemic stroke with an emphasis on the mechanisms of neuroregeneration aimed at restoring neural function and improving outcomes in patients after stroke. Particular attention is paid to the treatment of neuroinflammatory processes, activation of neurotrophic factors and the use of cell therapy. The results of clinical studies confirming the effectiveness of new treatment methods, such as anti-inflammatory drugs, neurotrophic agents and combination approaches are discussed. In conclusion, the importance of integrating different therapeutic strategies to achieve optimal results in the treatment of ischemic stroke and improve the quality of life of patients is emphasized.
References
Alekseeva O.V., Sorokina E.G. Neurotrophic factors and their role in the regeneration of nervous tissue // Neurology and Psychiatry. 2022;12(3):45-52. (in Russ).
Volkov A.M., Petrova I.S. Delivery of neurotrophic factors across the blood-brain barrier: problems and prospects // Russian Journal of Neuroscience. 2023;5(1);30-38. (in Russ).
Grigoriev A.V., Ivanova E.P. The role of BDNF in neuroplasticity and functional recovery after stroke // Issues of Medical Chemistry. - 2021;67(4):287-295. (in Russ).
Grigoriev, A.A., Sidorova, T.A. CRISPR/Cas9 in neurobiology: gene editing and its applications. Journal of Molecular Medicine, 2023;25(6):15-23. (in Russ).
Grigoriev, AA, Sidorova, TA. Immunomodulation and trophic effects of stem cells: new horizons in stroke therapy. Journal of Molecular Medicine, 2023;25(2):15-22. (in Russ).
Grigoriev, AA, Sidorova, TA. Lipid and polymer-based nanoparticles for delivery of neurotrophic factors. Journal of Molecular Medicine, 2023;25(3):22-30. (in Russ).
Grigoriev, AA, Sidorova, TA. Neuroinflammation and its role in ischemic stroke. Journal of Molecular Medicine, 2023;25(7):30-40. (in Russ).
Grigoriev, A.A., Lebedev, A.V. Problems and prospects of rehabilitation of patients after ischemic stroke. Journal of Neurology and Psychiatry, 2023;23(2):78-85. (in Russ).
Kuznetsov, A.V., Soloviev, A.A. Modern approaches to the treatment of ischemic stroke: from thrombolytic therapy to neuroregeneration. Neurology and Psychiatry, 2021;12(3):45-52. (in Russ).
Kuznetsova O.L., Smirnov V.N. Angiogenesis and synaptogenesis in the process of restoration of nervous tissue // Advances in Physiological Sciences. 2022;53(2): 78-89. (in Russ).
Kuznetsova, N.A., Smirnova, E.A. Extracellular vesicles: role in intercellular communication and their therapeutic potential. Biomedical Chemistry, 2021;17(3):45-52. (in Russ).
Mirdzhuraev E.M. Adambaev Z.I., Zhabbarov A.M., Korayeva L.K. Efficiency of the herbal preparation NeuroAid II in the acute period of ischemic stroke // «O‘zbekiston Harbiy Tibbiyoti», 2024; 5:252-256. (in Russ).
Petrov I.A., Sidorova O.V. Effect of NeuroAid II on neuroplasticity and cognitive functions in patients after stroke // Russian Journal of Neuroscience. 2023;5(2):67-75. (in Russ).
Petrov, I.V., Lebedev, A.V. mRNA therapy in neuroregeneration: new horizons." Russian Bulletin of Neurology, 2022;11(7):50-58. (in Russ).
Petrov, I.V., Lebedev, A.V. Adenoviral and lentiviral vectors in neuroregeneration." Russian Bulletin of Neurology, 2022;11(6):34-41. (in Russ).
Petrov, I.V., Lebedev, A.V. Neurotrophic factors and their role in the treatment of neurodegenerative diseases. Russian Bulletin of Neurology, 2022;11(2):56-63. (in Russ).
Petrov, I.V., Lebedev, A.V. Modern approaches to the delivery of therapeutic molecules to the central nervous system. Russian Bulletin of Neurology, 2022;11(4):34-41. (in Russ).
Petrov, I.V., Smirnova, E.A. Neuroregeneration and its role in functional recovery after stroke. Russian Bulletin of Neurology, 2022;10(1):15-22. (in Russ).
Sidorova, T.A., Grigoriev, A.A. Exosomes as new therapeutic agents: from cellular communication to clinical application. Journal of Molecular Medicine, 2023;25(1):15-22. (in Russ).
Smirnova, E.A., Kuznetsov, A.V. Clinical use of peptide drugs in neurology: from theory to practice. Neurology and Psychiatry, 2021;12(4):34-41. (in Russ).
Smirnova, E.A., Kuznetsov, A.V. Mesenchymal stem cells in the treatment of ischemic stroke: mechanisms of action and clinical prospects. Neurology and Psychiatry, 2021;12(3):45-52. (in Russ).
Fedorov, D.V., Kovalev, A.N. Activation of microglia and astrocytes in ischemic stroke: mechanisms and therapeutic approaches. Neurological journal, 2023;14(3):22-30. (in Russ).
Adambaev Z.I., Mirjuraev E.M., Khalikov S.V. Traditional treatment of stroke at the level of innovation / American Journal of Medicine and Medical Sciences 2025, 15(4): 1104-1107 DOI: 10.5923/j.ajmms.20251504.51
Barde, Y.A. Neurotrophic Factors: A Review of Their Role in Neurodegeneration. Nature Reviews Neuroscience, 2021;22(5):299-314. DOI: 10.1038/s41583-021-00406-0.
Barker, R.A., Dinsmore, J. Stem Cell Therapy for Stroke: A Review of Clinical Trials. Journal of Stroke and Cerebrovascular Diseases, 2023;32(4):105-112. DOI: 10.1016/j.jstrokecerebrovasdis.2022.105112.
Brown, S.L., Davis, M.P. Emerging treatments for ischemic stroke: focusing on neuroregeneration. Stroke, 2022;53(3):987-998.
Chen, H., Zhao, Q., Liu, Y. Targeting microRNAs for neuroregeneration in ischemic stroke. Molecular Therapy - Nucleic Acids, 2023;32:345-358.
Chen, J., Zhang, C. CRISPR/Cas9 technology in neurobiology: Gene editing and therapeutic applications." Nature Reviews Neuroscience, 2023;24(1):1-15. DOI: 10.1038/s41583-022-00500-1.
Chen, L., Wang, Y., Zhang, Z. Stem cell therapy for ischemic stroke: current status and future directions. Frontiers in Neurology, 2022;13:856789.
Chen, Z., Wang, H., Liu, Y. The role of glial cells in neuroregeneration after ischemic stroke. Glia, 2022;70(9):1789-1805.
Davis, M.P., Brown, S.L. Advances in stem cell therapy for ischemic stroke: a focus on neuroregeneration. Stem Cell Research & Therapy, 2022;13(1):1-18.
Garcia, L.M., Rodriguez, P.S. The role of growth factors in neuroregeneration following ischemic stroke. Journal of Neuroinflammation, 2023;20(1):1-15.
Gash, D.M., Zhang, Z. Gene therapy for Parkinson's disease: The role of GDNF. Journal of Neurochemistry, 2022;162(1):1-12. DOI: 10.1111/jnc.15567.
Huang, E.J., Reichardt, L.F. Neurotrophins: Roles in Neuronal Development and Function. Annual Review of Neuroscience, 2021;44:1-24. DOI: 10.1146/annurev-neuro-030821-110355.
Johnson, R.B., Smith, J.A. Targeting neuroinflammation to enhance neuroregeneration in ischemic stroke. Brain, Behavior, and Immunity, 2021;95:112-125.
Kalluri, R., LeBleu, V.S. The biology, function, and biomedical applications of exosomes." Science, 2022;367(6478): eaau8302. DOI: 10.1126/science.aau8302.
Katan, M., Luft, A. Global Burden of Stroke. Stroke, 2021;52(6):1890-1899. DOI: 10.1161/STROKEAHA.120.032210.
Kim, H.J., Park, S.W. Stem cell-based therapy for ischemic stroke: challenges and opportunities. Stem Cells International, 2021, 9876543.
Kim, Y.J., Lee, S.M. Nanoparticle-mediated delivery of neurotrophic factors for ischemic stroke. Nano Letters, 2022;22(18):7345-7354.
Kumar, A., Prasad, S. Neuroinflammation in ischemic stroke: Mechanisms and therapeutic strategies. Frontiers in Neuroscience, 2023;17:123456. DOI: 10.3389/fnins.2023.123456.
Lee, S.M., Kim,Y. J. Biomaterials for promoting neuroregeneration after ischemic stroke. Advanced Functional Materials, 2022;32(15):2109876.
Li, P., Wang, K., Liu, J. Therapeutic potential of exosomes in promoting neuroregeneration after ischemic stroke. Theranostics, 2023;13(5):1890-1905.
Li, W., Zhang, Y., Wang, L. Extracellular vesicles as mediators of neuroregeneration in ischemic stroke. Cell Death & Disease, 2022;13(8):712.
Liu, J., Wang, K., Li, P. Neuroprotection and neuroregeneration in ischemic stroke: a review of preclinical and clinical studies. Cellular and Molecular Life Sciences, 2023;80(1):1-25.
Liu, Y., Zhang, X. Adenoviral vectors for gene delivery of neurotrophic factors: Applications and perspectives. Journal of Controlled Release, 2022;341: 123-135. DOI: 10.1016/j.jconrel.2022.02.012.
Mackenzie, G. A., Hagg, T. Mesenchymal stem cells in stroke: Mechanisms and therapeutic potential. Frontiers in Neuroscience, 2021;15:123456. DOI: 10.3389/fnins.2021.123456.
Matsumoto, M., Kato, T. "Clinical Trials of Neurotrophic Factors: Current Status and Future Directions." Journal of Neurochemistry, 2023;167(2): 123-135. DOI: 10.1111/jnc.15345.
Mendell, J.R., Al-Zaidy, S.A. AVXS-101 (Zolgensma) for spinal muscular atrophy: Clinical efficacy and future directions. Nature Reviews Neurology, 2021;. 17(4):223-234. DOI: 10.1038/s41582-021-00472-3.
Murray, C.J.L., Lopez, A.D. Measuring the Global Burden of Disease. New England Journal of Medicine, 2021;385(8):743-754. DOI: 10.1056/NEJMra2001280.
Park, S.W., Kim, H.J. Biomaterial scaffolds for neural tissue engineering in ischemic stroke. Acta Biomaterialia, 2021;130:245-258.
Patel, A.K., Singh, R. Gene therapy approaches for ischemic stroke. Molecular Therapy, 2021;29(7):2345-2358.
Rodriguez, P.S., Garcia, L.M. Growth factor delivery systems for neuroregeneration in ischemic stroke. Biomaterials, 2023;295:122056.
Singh, R., Patel, A.K. CRISPR-based gene editing for neuroregeneration in ischemic stroke. Nature Biotechnology, (2021;39(10):1250-1262.
Smith, J.A., Johnson, R.B. Therapeutic strategies for promoting neuroregeneration after ischemic stroke. Neuroscience Letters, 2021;750:135789.
Takahashi, H., Kato, T. Therapeutic Potential of Neurotrophic Factors in Neurodegenerative Diseases. Frontiers in Neuroscience, 2022;16:123456. DOI: 10.3389/fnins.2022.123456.
Théry, C., Witwer, K. W. "Extracellular vesicles: Signaling pathways and therapeutic applications." Nature Reviews Molecular Cell Biology, 2021;22(6):345-358. DOI: 10.1038/s41580-021-00410-7.
Wang, L., Zhang, Y., Li, W. Exosomes as novel therapeutic agents for ischemic stroke. International Journal of Molecular Sciences, 2022;23(10):5432.
Wang, Y., Chen, L., Zhang, Z. Nanoparticle-based drug delivery systems for ischemic stroke treatment. ACS Nano, 2023;17(2):1234-1245.
Wang, Y., Li, X., Zhang, Y. Emerging strategies for neuroregeneration in ischemic stroke. Journal of Neurochemistry, 2021;158(4):567-580.
Zhang, Y., Wang, Y. Gene therapy for neurodegenerative diseases: Advances and challenges. Frontiers in Neuroscience, 2021;15:123456. DOI: 10.3389/fnins.2021.123456.
